Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: Case study using a model drug

European Journal of Pharmaceutical Sciences

Volumn 64, Issue , 2014, Pages 26-36

  Yanamandra, Sarala ^a   Venkatesan, Natarajan ^b   Kadajji, Veeran Gowda ^a   Wang, Zhijun ^a   Issar, Manish ^a   Betageri, Guru V ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Bioavailability; First pass metabolism; In vivo; Lovastatin; Proliposomes

Indexed keywords

CHOLESTEROL; DIMYRISTOYL PHOSPHATIDYLGLYCEROL; HYDROGENATED EGG PHOSPHATIDYLCHOLINE; LIPOSOME; MEVINOLIN; ORGANIC SOLVENT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PROLIPOSOME; SOY PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG; TABLET;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL MEMBRANE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; EVAPORATION; FIRST PASS EFFECT; HEPATIC FIRST PASS METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER METABOLISM; MALE; MICROCAPSULE; NONHUMAN; PARALLEL ARTIFICIAL MEMBRANE PERMEABILITY ASSAY; POWDER; RAT; TABLET COMPRESSION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; LIVER; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; TABLET;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; LIPOSOMES; LIVER; LOVASTATIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; TABLETS;

EID: 84907176154     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.08.008     Document Type: Article

References (30)

1. S.A. Agnihotri, K.S. Soppimath, and G.V. Betageri Controlled release application of multilamellar vesicles: a novel drug delivery approach Drug Deliv. 17 2010 92 101
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
3. P.V. Balimane, Y.H. Han, and S. Chong Current industrial practices of assessing permeability and p-glycoprotein interaction AAPS J. 8 2006 E1 E13
4. H. Chen, V. Torchilin, and R. Langer Lectin-bearing polymerized liposomes as potential oral vaccine carriers Pharm. Res. 13 1996 1378 1383
5. S.J. Chung Future drug delivery research in South Korea J. Control. Release 62 1999 73 79
6. J.M. Custodio, C.Y. Wu, and L.Z. Benet Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption Adv. Drug Deliv. Rev. 60 2008 717 733
7. E.F. Fiese, and T.A. Hagen Preformulation L. Lachman, H.A. Liberman, J.L. Kanig, The Theory and Practice of Industrial Pharmacy third ed. 1986 Varghese Publishing House Bombay 171 196
8. S.M. Fischer, M. Brandl, and G. Fricker Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers Eur. J. Pharm. Biopharm. 79 2011 416 422
9. K.J. Frank, K.M. Rosenblatt, U. Westedt, P. Holig, J. Rosenberg, M. Magerlein, G. Fricker, and M. Brandl Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement Int. J. Pharm. 437 2012 288 293
10. X. Han, C. Ghoroi, and R. Dave Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading Int. J. Pharm. 442 2013 74 85 10.1016/j.ijpharm.2012.08.004
11. J.M. Henwood, and R.C. Heel Lovastatin: a preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia Drugs 36 1988 429 454
12. P.S. Hiremath, K.S. Soppimath, and G.V. Betageri Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine Int. J. Pharm. 380 2009 96 104
13. D. Horter, and J.B. Dressman Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv. Drug Deliv. Rev. 46 2001 75 87
14. Y. Hu, J. Wang, Z. Zhi, T. Jiang, and S. Wang Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug J. Colloid Interface Sci. 363 2011 410 417 10.1016/j.jcis.2011.07.022
15. B.H. Jung, B.C. Chung, S.J. Chung, M.H. Lee, and C.K. Shim Prolonged delivery of nicotine in rats via nasal administration of proliposomes J. Control. Release 66 2000 73 79
16. G.N. Kaluderovic, A. Dietrich, H. Komeera, J. Kuntsche, K. Mader, T. Mueller, and R. Paschke Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II) Eur. J. Med. Chem. 54 2012 567 572 10.1016/j.ejmech.2012.06.004
17. J. Kanzer, I. Tho, G.E. Flaten, M. Magerlein, P. Holig, G. Fricker, and M. Brandl In-vitro permeability of screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier J. Pharm. Pharmacol. 62 2010 1591 1598
18. M. Li, N. Qiao, and K. Wang Influence of sodium lauryl sulfate and Tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour Pharmaceutics 5 2013 508 524 10.3390/pharmaceutics5040508
19. R. Liu, J.B. Cannon, and S.Y.L. Paspal Liposomes in solubilization R. Liu, Water-insoluble Drug Formulation second ed. 2008 CRC Press Boca Raton, Florida 375 416
20. E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
21. S.G. Patel, and S.J. Rajput Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes AAPS PharmSciTech 10 2009 660 669 10.1208/s12249-009-9249-7
22. Z. Pavelic, N. Skalko-Basnet, and R. Schubert Liposomal gels for vaginal drug delivery Int. J. Pharm. 219 2001 139 149
23. N.I. Payne, P. Timmins, C.V. Ambrose, M.D. Ward, and F. Ridgway Proliposomes: a novel solution to an old problem J. Pharm. Sci. 75 1986 325 329
24. M.N. Sarbolouki, S. Parsaee, and P. Kosary Mixed micelle proliposomes for preparation of liposomes containing amphotericin B, in-vitro and ex-vivo studies PDA J. Pharm. Sci. Technol. 54 2000 240 246
25. A. Supersaxo, W.R. Hein, and H. Steffen Mixed micelles as a proliposomal, lymphotropic drug carrier Pharm. Res. 8 1991 1286 1291
26. G. Suresh, K. Manjunath, V. Venkateswarlu, and V. Satyanarayana Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles AAPS PharmSciTech 8 2007 E162 E170 10.1208/pt0801024
27. P.H. Tran, T.T. Tran, and B.J. Lee Enhanced solubility and modified release of poorly water-soluble drugs via self-assembled gelatin-oleic acid nanoparticles Int. J. Pharm. 455 2013 235 240 10.1016/j.ijpharm.2013.07.025
28. United States Pharmacopoeia, 2007. Lovastatin Tablets, p. 2502.
29. H.D. Williams, N.L. Trevaskis, S.A. Charman, R.M. Shanker, W.N. Charman, C.W. Pouton, and C.J. Porter Strategies to address low drug solubility in discovery and development Pharmacol. Rev. 65 2013 315 499 10.1124/pr.112.005660
30. Y. Zhao, X. Liu, J. Wang, and S. Zhang Insight into the cosolvent effect of cellulose dissolution in imidazolium-based ionic liquid systems J. Phys. Chem. B 117 2013 9042 9049 10.1021/jp4038039